NEW COMPLEX TREATMENT METHOD OF PATIENTS WITH CHRONIC LUPUS ERYTHEMATOSUS WITH ANTI-INFLAMMATORY AND METABOLIC DRUGS

Abstract

On the basis of clinical and laboratory researches established the changes that characterize the metabolic abnormalities in patients with chronic chronic lupus erythematosus, primarily severe disseminated forms. A complex method of treating these patients using antiinflammatory agent dapsone, hepatoprotector with antioxidant properties Glutargin and Magnerot magnesiumcontaining drug that helps to normalize the violations and helps to reduce the period of treatment and increasing proportion of patients with a state of clinical remission and improvement.